anti-diabetic drug pathway rosiglitazone drug pathway 2016-02-02T12:09:15Z PW:0002476 The pharmacokinetics and pharmacodynamics pathway of rosiglitazone, an anti-diabetic drug. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug. In several countries the drug was withdrawn from the market due to its side effects. pathway vpetri